US parameters based on variations in the IVC diameter were unsuccessful in estimating CVP in MV children aged 2 days to 12 years.
CVP is a crucial hemodynamic parameter in several cases within PICUs [1–4], and typically requires invasive measurement via a SVC-CVC [1]. Similar to adults [5, 17], CVP in SB children can also be assessed using US measurements of IVC diameter variations [18]. However, while it is well-established that CVP cannot be accurately estimated by US measurements of the IVC in MV adults [5, 6], the relevance of these findings for MV children in the PICU remained debated. To date, only six single-center studies have explored this issue [7–12], often combining data from SB and MV children or using varying CVP measurement techniques that deviate from international guidelines, leading to inconsistent results. Therefore, validating the accuracy of CVP evaluation via IVC US measurements in a large cohort of MV children was essential for pediatric intensivists.
This first prospective multicenter study has several notable strengths. This is the only study to date that has included such a large cohort of 120 exclusively MV children, whose general characteristics closely resemble those of the pediatric population usually admitted to the PICU [19]. Our CVP measurement protocol adhered strictly to the guidelines set by the European Society of Pediatric and Neonatal Intensive Care [1], employing a CVC placed at the junction of the RA and the SVC. Finally, in our study, all US measurements were performed by experienced pediatric intensivists at each participating PICU who strictly adhered to a standardized protocol, thereby minimizing the risk of error.
Our results are in accordance with those previously reported by Basu et al. in a single-center study involving 50 MV children [9] which noted the lack of correlation between CVP and IVC US measurements. In contrast, other studies have often analyzed mixed populations of SB and MV children [7, 8, 10–12], making their data difficult to interpret. Furthermore, in the studies that included MV children, the level of positive end-expiratory pressure (PEEP) was reported in only two out of six studies [7, 11]. Only one other single-center pediatric study, involving 15 children, systematically used an SVC-CVC for hemodynamic profiling with a Pulse Index Contour Cardiac Output device [10]. The results of this study are difficult to interpret due to repeated measurements in both SB and MV children. Additionally, Basu et al. noted that only two-thirds of the children had CVP measurements using an SVC-CVC [9].
Despite the strict protocols for CVP and US data acquisition, our study, conducted under real-world conditions at the bedside of MV children in six PICUs, may have been biased by the exclusion of patients with extreme CVP values due to the urgent need for critical management, such as in cases of severe hypovolemic shock with very low CVP or extreme congestive heart failure with high RA pressure. Notably, one-third of the included patients had CVP values either below 4 mmHg (n = 17) or above 12 mmHg (n = 17). Another potential limitation is the reduced statistical power (P = 0.77) in our subgroup of patients older than two years (n = 44). While these findings should be generalized with caution, it is important to highlight that no previous study has reported such a large cohort of MV patients in this age group with CVP measurements conducted strictly according to the guidelines [1]. All these factors collectively enhance the external validity of our results.
In conclusion, this prospective multicenter study found no significant correlation between CVP and IVC US measurements in MV children aged 2 days to 12 years of age. These findings suggest that IVC US measurements should not be relied upon for precise CVP estimation in this population. However, the effectiveness of the semiquantitative method based on the visual assessment of the IVC without detailed calculations [17] still needs to be rigorously evaluated in the PICU.